Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Market Cap	420.91B +5.7%
Revenue (ttm)	166.80B +3.1%
Net Income	3.07B -71.4%
EPS	41.27 -71.4%
Shares Out	74.34M
PE Ratio	137.19
Forward PE	37.06
Dividend	106.00 (1.87%)
Ex-Dividend Date	Jun 29, 2026

Volume	222,900
Open	5,699.00
Previous Close	5,662.00
Day's Range	5,622.00 - 5,701.00
52-Week Range	5,030.00 - 6,140.00
Beta	0.26
Analysts	Hold
Price Target	5,535.00 (-2.55%)
Earnings Date	May 8, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sh...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,731
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4967

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.

Analyst Summary

According to 8 analysts, the average rating for 4967 stock is "Hold." The 12-month stock price target is ¥5,535, which is a decrease of -2.55% from the latest price.

Price Target

¥5,535

(-2.55% downside)

Analyst Consensus: Hold